Сравнительный анализ результатов хирургического и эндоваскулярного методов лечения ишемической болезни сердца

Сравнительный анализ результатов хирургического и эндоваскулярного методов лечения ишемической болезни сердца

Автор: Синявин Геннадий Валентинович, Гавриленко Александр Васильевич, Хрипков Александр Сергеевич

Журнал: Хирургическая практика @spractice

Статья в выпуске: 1, 2012 года.

Бесплатный доступ

Ишемическая болезнь сердца (ИБС) является наиболее распространенной причиной смерти в странах Северной Америки и Европы. В последние десятилетия XX века аортокоронарное шунтирование (АКШ) было предпочтительным методом лечения пациентов с ИБС. В последнее десятилетие отмечается рост частоты применения эндоваскулярного лечения ИБС. Хирургические методы реваскуляризации должны быть приоритетным выбором при обширной ишемии миокарда, так как снижают ее эффективнее, чем медикаментозная терапия. Повторная операция чаще необходима пациентам, которым проводилось стентирование коронарных артерий, чем больным, которым выполняли АКШ. У пациентов, которым применяли АКШ выживаемость выше, а потребность в повторной реваскуляризации ниже по сравнению с пациентами, которым проводили стентирование коронарных артерий. Стенты с лекарственным покрытием значительно снизили уровень рестенозов по сравнению с непокрытыми металлическими стентами.

Еще

Ишемическая болезнь сердца, аортокоронарное шунтирование, стентирование коронарных артерий, реваскуляризация миокарда, транслюминальная баллонная ангиопластика, инфаркт миокарда

Короткий адрес: https://sciup.org/142211471

IDR: 142211471

Список литературы Сравнительный анализ результатов хирургического и эндоваскулярного методов лечения ишемической болезни сердца

  • Lloyd-Jones D., Adams R., Carnethon M. et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee//Circulation. 2009. Vol.119 (3). P. 480-486.
  • Ford E.S., Ajani U.A., Croft J.B. et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000//N. Engl. J. Med. 2007. Vol. 356 (23). P. 2388-2398.
  • Ross H. Cardiology. 2000. 58 p.
  • Mack M.J., Brown P.P., Kugelmass A.D. et al. Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 surgical and percutaneous procedures//Ann. Thorac. Surg. 2004. Vol. 77. P. 761-766.
  • Park S.J., Kim Y.H., Lee B.K. et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation//J. Am. Coll. Cardiol. 2005. Vol. 45. P. 351-356.
  • Grube E., Silber S., Hauptmann K.E. et al. TAXUS I: six-and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions//Circulation. 2003. Vol. 107. P. 38-42.
  • Sawhney N., Moses J.W., Leon M.B. et al. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents//Circulation. 2004. Vol. 110. P. 374-379.
  • Favaloro R.G. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique//Ann. Thorac. Surg. 1968 Apr. Vol. 5 (4). P. 334-339.
  • Бураковский В.И., Бокерия Л.А. Сердечно-сосудистая хирургия. М.: Медицина, 1996. 752 с.
  • Бокерия Л.А., Ступаков И.Н., Самородская И.В. Результаты применения стентов у больных ишемической болезнью сердца (обзор мета-анализов)//Кардиология и сердечно-сосудистая хирургия. 2008. № 2. С. 12-17.
  • Gruntzig A.R., Senning A., Siegenthaler W.E. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty//N. Engl. J. Med. 1979. Vol. 301. P. 61-68.
  • Serruys P.W., de Jaegere P., Kiemeneiji F. et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Stusy Group//N. Engl. J. Med. 1994. Vol. 331. P. 489-495.
  • Serruys P.W., Ong A., Morice M.C. et al. Arterial Revascularization Therapies Study Part II -Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions//EuroInterv. 2005. Vol. 2. P. 147-156.
  • Jones R.H., Kesler K., Phillips H.R. 3rd. et al. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease//J. Thorac. Cardiovasc. Surg. 1996. Vol. 111. P. 1013-1025.
  • Chaitman B.R., Ryan T.J., Kronmal R.A. Coronary Artery Surgery Study (CASS): comparability of 10 year survival in randomized and randomizable patients//J. Am. Coll. Cardiol. 1990. Vol. 16. P. 10711078.
  • Alderman E.L., Bourassa M.G., Cohen L.S. et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study//Circulation. 1990. Vol. 82. P. 1629-1646.
  • Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery: quality of life in patients randomly assigned to treatment groups//Circulation. 1983. Vol. 68. P. 951-960.
  • Takaro T., Hultgren H.N., Lipton M.J. et al. The VA cooperative randomized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions//Circulation. 1976. Vol. 54. P. 107-117.
  • Martin Rufi, Karl Werdan, Jochen Cremer et al. Different Treatment Options in Chronic Coronary Artery Disease When Is It the Time for Medical Treatment, Percutaneous Coronary Intervention or Aortocoronary Bypass Surgery?//Dtsch. Arztebl. Int. 2009 April. Vol. 106 (15). S. 253-261.
  • Fox K., Garcia M.A., Ardissino D. et al. Guidelines on the management of stable angina pectoris; the experts of the European Society of Cardiology on the management of stable angina pectoris//Eur. Heart J. 2006. Vol. 27 (11). P. 1341-1381.
  • Bravata D.M. et al. Systematic Review: The comparative effectiveness of percutaneous coronary interventions and coronary artery bypass surgery//Ann. Intern. Med. 2007. Vol. 147. P. 703-716.
  • Hachamovitch R. et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography//Circulation. 2003. Vol. 107. P. 2900-2907.
  • BARI Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The bypass angioplasty revascularisation investigation (BARI) investigators//N. Engl. J. Med. 1996. Vol. 335. P. 217-225.
  • CABRI Trial Participants. First year results of CABRI (coronary angioplasty versus bypass revascularisation investigation). CABRI trial participants//Lancet. 1995. Vol. 346. P. 1179-1184.
  • King S.B., Lembo N.J., Weintraub W.S. et al. A randomised trial comparing coronary angioplasty with coronary bypass surgery. Emory angioplasty versus surgery trial (EAST)//N. Engl. J. Med. 1994. Vol. 331. P. 1044-1050.
  • Rodriguez A., Bernardi V., Navia J. et al. ERACI II Investigators. Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results//J. Am. Coll. Cardiol. 2001. Vol. 37. P. 51-58.
  • Rodriguez A., Rodriguez Alemparte M., Baldi J. et al. Coronary stenting versus coronary bypass surgery in patients with multiple vessel disease and significant proximal LAD stenosis: results from the ERACI II study//Heart. 2003 February. Vol. 89 (2). P. 184-188.
  • SoS Investigators Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial//Lancet. 2002. Vol. 360. P. 965-970.
  • De Feyter P.J., Serruys P.W., Unger F. et al. Bypass surgery versus stenting for the treatment of multivessel disease in patients with unstable angina compared with stable angina//Circulation. 2002. Vol. 105. P. 23672372.
  • Weintraub W.S., Mahoney E.M., Zhang Z. et al. One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial//Heart. 2004 July. Vol. 90 (7). P. 782-788.
  • Hueb W., Lopes N.H., Gersh B.J. et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease//Circulation. 2007. Vol. 115. P. 1082-1089.
  • The BARI Investigators. Seven-year outcome in the bypass angioplasty revascularization investigation (BARI) by treatment and diabetic status//J. Am. Coll. Cardiol. 2000. Vol. 35. P. 1122-1129.
  • King S.B. III, Kosinnski A.S., Guyton R.A. et al. The Emory Angioplasty versus Surgery Trial (EAST) Investigators. Eight-year mortality in the Emory angioplasty versus surgery trial (EAST)//J. Am. Coll. Cardiol. 2000. Vol. 35. P. 1116-1121.
  • Hlatky M., Rogers W., Johnstone I. et al. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery//N. Engl. J. Med. 1997. Vol. 226. P. 92-99.
  • Weintraub W.S., Mauldin P.D., Becker E. et al. A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the Emory angioplasty versus surgery trial (EAST)//Circulation. 1995. Vol. 92. P. 2831-2840.
  • Hlatky M.A., Rogers W.J., Johnstone I. et al. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery//N. Engl. J. Med. 1997. Vol. 336. P. 92-99.
  • Sculpher M.J., Seed P., Henderson R.A. et al. Health service costs of coronary angioplasty and coronary artery bypass surgery: the randomised intervention treatment of angina (RITA) trial//Lancet. 1994. Vol. 344. P. 927-930.
  • Henderson R.A., Pocock S.J., Sharp S.J. et al. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting//Lancet. 1998. Vol. 352. P. 1419-1425.
  • Rodriguez A., Mele E., Peyregne E. et al. Three-year follow-up of the Argentine randomised trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI)//J. Am. Coll. Cardiol. 1996. Vol. 27. P. 1178-1184.
  • Weintraub W.S., Becker E.R., Mauldin P.D. et al. Costs of revascularisation over eight years in the randomised and eligible patients in the Emory angioplasty versus surgery trial (EAST)//Am. J. Cardiol. 2000. Vol. 86. P. 747-752.
  • Nordmann A.J., Hengstler P., Leimenstoll B.M. et al. Clinical outcomes of stents versus balloon angioplasty in non-acute coronary artery disease: a meta-analysis of randomized controlled trials//Eur. Heart J. 2004. Vol. 25. P. 69-80.
  • Hannan E.L., Racz M.J., Arani D.T. et al. A comparison of short-and long-term outcomes for balloon angioplasty and coronary stent placement//J. Am. Coll. Cardiol. 2000. Vol. 36. P. 395-403.
  • Versaci F., Gaspardone A., Tomai F. et al. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery//N. Engl. J. Med. 1997. Vol. 336. P. 817-822.
  • Krumholz H.M., Cohen D.J., Williams C. et al. Health after coronary stenting or balloon angioplasty: results from the Stent Restenosis Study//Am. Heart. J. 1997. Vol. 134. P. 337-344.
  • Rodriguez A.E., Santaera O., Larribau M. et al. Coronary stenting decreases restenosis in lesions with early loss in luminal diameter 24 hours after successful PTCA//Circulation. 1995. Vol. 91. P. 1397-1402.
  • Bittl J.A., Chew D.P., Topol E.J. et al. Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty//J. Am. Coll. Cardiol. 2004. Vol. 43. P. 936-942.
  • Dietz U., Rupprecht H.J., de Belder M.A. et al. Angiographic analysis of the angioplasty versus rotational atherectomy for the treatment of diffuse in-stent restenosis trial (ARTIST)//Am. J. Cardiol. 2002. Vol. 90. P. 843-847.
  • Haager P.K., Schiele F., Buettner H.J. et al. Insufficient tissue ablation by rotational atherectomy leads to worse long-term results in comparison with balloon angioplasty alone for the treatment of diffuse instent restenosis: insights from the intravascular ultrasound substudy of the ARTIST randomized multicenter trial//Catheter Cardiovasc. Interv. 2003. Vol. 60. P. 25-31.
  • Seshadri N., Whitlow P.L., Acharya N. et al. Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era//Circulation. 2002. Vol. 106. P. 2346-2350.
  • Bertrand M.E., Rupprecht H.J., Urban P. et al. For the CLASSICS Investigators. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS)//Circulation. 2000. Vol. 102. P. 624-629.
  • Juergens C.P., Wong A.M., Leung D.Y. et al. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation//Am. Heart J. 2004. Vol. 147. E. 15.
  • Muller C., Buttner H.J., Petersen J. et al. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents//Circulation. 2000. Vol. 101. P. 590-593.
  • Cantor W.J., Madan M., O'Shea J.C. et al. Bailout use of platelet glycoprotein IIb-IIIa inhibition during coronary stent implantation: observations from the ESPRIT trial//J. Invasive Cardiol. 2005. Vol. 17. P. 360-364.
  • Islam M.A., Blankenship J.C., Balog C. et al. Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT)//Am. J. Cardiol. 2002. Vol. 90. P. 916-921.
  • Brophy J.M., Belisle P., Joseph L. Evidence for use of coronary stents: a hierarchical bayesian meta-analysis//Ann. Intern. Med. 2003. Vol. 138. P. 777-786.
  • van Domburg R.T., Takkenberg J.J.M., Noordzjij L.J. et al. Late outcome after stenting or coronary artery bypass surgery for the treatment of multivessel disease: A single-center matched-propensity controlled cohort study//Ann. Thorac. Surg. 2005. Vol. 79. P. 1563-1569.
  • Smith S.C., Feldman T.E., Hirshfeld J.W. et al. American College of Cardiology/American Heart Association Task Force on practice guidelines; American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions Writing Committee to update the 2001 guidelines for percutaneous coronary intervention ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention -summary article: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 guidelines for percutaneous coronary intervention)//Circulation. 2006. Vol.113. P. 156-175.
  • Silber S., Albertsson P., Aviles F.F. et al. Task Force for percutaneous coronary interventions of the European Society of Cardiology Guidelines for percutaneous coronary interventions. The Task Force for percutaneous coronary interventions of the European Society of Cardiology//Eur. Heart J. 2005. Vol. 26. P. 804-847.
  • Dawkins K.D., Gershlick T., de Belder M. et al. Joint Working Group on percutaneous coronary intervention of the British Cardiovascular Intervention Society and the British Cardiac Society Percutaneous coronary intervention: Recommendations for good practice and training//Heart. 2005. Vol. 91 (Suppl. 6). P. 1-27.
  • Taggart D.P., Thomas B. Ferguson Lecture. Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know//Ann. Thorac. Surg. 2006. Vol. 82. P. 1966-1975.
  • Sigwart U., Puel J., Mirkovitch V. et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty//N. Engl. J. Med. 1987. Vol. 316. P. 701-706.
  • Fischman D.L., Leon M.B., Baim D.S. et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators//N. Engl. J. Med. 1994 Aug 25. Vol. 331 (8). P. 496-501.
  • Schomig A., Kastrati A. Long lesions, long stents and the long process of stent optimization [editorial]//J. Am. Coll. Cardiol. 1999. Vol. 34. P. 660-662 DOI: 10.1016/S0735-1097(99)00302-2
  • Kasaoka S., Tobis J.M., Akiyama T. et al. Angiographic and intravascular ultrasound predictors of in-stent restenosis//J. Am. Coll. Cardiol. 1998 Nov 15. Vol. 32 (6). P. 1630-1635.
  • Albiero R., Adamian M., Kobayashi N. et al. Short-and intermediate-term results of (32)P radioactive beta-emitting stent implantation in patients with coronary artery disease: The Milan Dose-Response Study//Circulation. 2000 Jan 4-11. Vol. 101 (1). P. 18-26.
  • Sousa J.E., Seruys P.W., Costa M.A. New Frontiers in Cardiology. Drug Eluting Stents Part 1//Circulation. 2003. Vol. 107. P. 2274-2286.
  • Lemos P.A., Serruys P.W., Sousa J.E. Drug-eluting stent cost versus benefit//Circulation. 2002. Vol. 107. P. 3003-3013.
  • Fattori R., Piva T. Drug-eluting stents in vascular intervention//Lancet. 2003. Vol. 361. P. 247-249.
  • Sousa J.E., Serruys P.W., Costa M.A. New frontiers in cardiology. Drug eluting stents Part II//Circulation. 2003. Vol. 107. P. 2383-2394.
  • Colombo A., Drzewiecki J., Banning E. et al. Randomized study to assess the effectiveness of slow and moderate release polymer based paclitaxel-eluting stents for coronary artery lesions//Circulation. 2003. Vol. 108. P. 788-799.
  • Stone G.W., Ellis S.G., Cox E. et al. One year clinical results with the slow-release polymer-based, paclitaxel-eluting TAXUS stent. The TAXUS IV Trial//Circulation. 2004. Vol. 109. P. 1942-1947.
  • Holmes D.R., Leon M.B., Moses J.W. et al. Analysis of 1-year clinical outcomes in the SIRIUS Trial. A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis//Circulation. 2004. Vol. 109. P. 634-640.
  • Schofer J., Schuiter M., Gershlick A.H. et al. Sirolimus-eluting stents for the treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS)//Lancet. 2003. Vol. 362. P. 1093-1099.
  • Grube E., Buellesfeld L., Mueller R. et al. Everolimus stent coating: promising procedural and 6-month angiographic and intravascular ultrasound follow-up results of the FUTURE I and II trial//Presented at the ESC Congress, Vienna, Austria. 2003. Vol. 362. P. 1093-1099.
Еще
Статья обзорная
SciUp 2024 © 2024 ©